Navigation Links
TechniKrom's Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical
Date:2/17/2009

GLENVIEW, Ill., Feb. 17 /PRNewswire/ -- TechniKrom, Inc. and Asahi Kasei Medical Co., Ltd., who have a longstanding partnership in the commercialization of equipment for use with Planova(TM) virus removal filters, have reached agreement for the transfer of TechniKrom's biopharmaceutical business to Asahi Kasei Medical's full ownership. The integration of operations will be marked by the formation of Asahi Kasei TechniKrom, Inc., a wholly owned subsidiary of Asahi Kasei Medical, on March 1, 2009. Financial terms were not disclosed.

The combination unites two market leaders in innovation: TechniKrom in the design, manufacture, and validation of custom biopharmaceutical processing equipment, and Asahi Kasei Medical in hollow-fiber and membrane adsorption technology. The unified product portfolio will further allow TechniKrom to advance its goal of contributing to human well-being by providing the biopharmaceutical industry with an expanded, integrated toolset to both lower the cost of drug manufacturing and achieve the highest innate drug product quality. "In addition to our existing products and services that we will continue to offer, we are extremely excited about the lineup of novel bioprocess separations products that Asahi Kasei TechniKrom will introduce over the coming months," said TechniKrom President and founder, Lou Bellafiore.

Asahi Kasei Medical's current business in the bioprocess field is centered on Planova(TM) filters and filtration systems for virus removal in the production of biopharmaceuticals. "The product line synergies with TechniKrom are a natural fit. This integration allows us to more seamlessly advance the worldwide expansion of our bioprocess operations with a base for the development, production, and sale of equipment and systems in the US, the world's leading biopharmaceuticals market," said Yasuyuki Yoshida, President of Asahi Kasei Medical.

Asahi Kasei TechniKrom will be headed by the current TechniKrom management team and will continue to operate from TechniKrom's Glenview, IL facility.

About TechniKrom

Founded in 1994, TechniKrom is a privately held, diversified engineering and qualification firm that provides technologically advanced blending, synthesis, filtration and purification equipment and services to the Biopharmaceutical, Pharmaceutical, and Nutraceutical Industries worldwide. TechniKrom equipment permits the lowest cost of production and highest innate product quality, especially in cGMP regulated environments. TechniKrom promotes the implementation of Manufacturing Science in biopharmaceutical manufacturing facilities.

For more information about TechniKrom, visit: http://www.technikrom.com.

About Asahi Kasei Group

The Asahi Kasei Group, headed by Asahi Kasei Corporation, is one of Japan's leading industrial groups, with consolidated sales of approximately US$17 billion. It provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care.

For more information about Asahi Kasei, visit: http://www.asahi-kasei.co.jp.


'/>"/>
SOURCE TechniKrom, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
5. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
6. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
9. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
10. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
11. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... a free AFM Luncheon for all SPIE attendees and Park ... CA, just one block from the San Jose Convention Center. The luncheon will ...
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences (“ProMIS” or the ... diseases, today announced it has issued a scientific white paper entitled “Results from ... series of commentaries from ProMIS’s scientific team offering insight into the Company’s product ...
(Date:2/22/2017)... , Feb. 22, 2017 Origin (Origin Agritech, LLC, ... trait and seed provider, and Arcadia (Arcadia ... that develops and commercializes agricultural productivity traits and nutritional products, today ... corn biotechnology product developed in China to ... regulatory trials. ...
(Date:2/22/2017)... and SAN DIEGO , Feb. ... "Company") (OTCQB:CELZ) announced today expansion of its translational ... cell product through establishment of laboratory facilities in ... at the San Diego BioLabs facility, a biotechnology ... Novartis, and Sanofi. In November 2016, ...
Breaking Biology Technology:
(Date:2/2/2017)... TOKYO , Feb. 1, 2017  Central ... innovative and meaningful advances worldwide, The Japan Prize ... Japan Prize, who have pushed the envelope in ... Information and Communication. Three scientists are being recognized ... outstanding achievements that not only contribute to the ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
(Date:1/26/2017)... 2017  Crossmatch, a leading provider of security and ... at combatting fraud, waste and abuse in assistance operations ... Action on Disaster Relief conference in Panama ... agencies and foreign assistance organizations throughout Latin ... are a largely unacknowledged problem in the foreign assistance ...
Breaking Biology News(10 mins):